| 1. |
Okada S, Hara M, Kobayakawa K, et al. Astrocyte reactivity and astrogliosis after spinal cord injury. Neurosci Res, 2018, 126: 39-43.
|
| 2. |
Tran AP, Warren PM, Silver J. Regulation of autophagy by inhibitory CSPG interactions with receptor PTPσ and its impact on plasticity and regeneration after spinal cord injury. Exp Neurol, 2020, 328: 113276.
|
| 3. |
李星, 李佳音, 肖志峰, 等. 脊髓損傷后膠質瘢痕在神經再生過程中作用的探討. 中國修復重建外科雜志, 2018, 32(8): 973-978.
|
| 4. |
Orr MB, Gensel JC. Spinal cord injury scarring and inflammation: therapies targeting glial and inflammatory responses. Neurotherapeutics, 2018, 15(3): 541-553.
|
| 5. |
孫麟, 馬迅, 劉強, 等. 丙酮酸乙酯通過抑制高遷移率族蛋白 1 減輕大鼠脊髓損傷后水腫及體外氧糖剝奪/復氧后星形膠質細胞腫脹的研究. 中華創傷骨科雜志, 2018, 20(12): 1079-1086.
|
| 6. |
Mu SW, Dang Y, Fan YC, et al. Effect of HMGB1 and RAGE on brain injury and the protective mechanism of glycyrrhizin in intracranial-sinus occlusion followed by mechanical thrombectomy recanalization. Int J Mol Med, 2019, 44(3): 813-822.
|
| 7. |
Sun L, Li M, Ma X, et al. Inhibiting high mobility group Box-1 reduces early spinal cord edema and attenuates astrocyte activation and aquaporin-4 expression after spinal cord injury in rats. J Neurotrauma, 2019, 36(3): 421-435.
|
| 8. |
呂聰, 孫麟, 馮皓宇, 等. 減少氧糖剝奪/復氧后脊髓星形膠質細胞凋亡: 抑制高遷移率族蛋白 B1/核轉錄因子 κB 通路的作用. 中國組織工程研究, 2019, 23(33): 5353-5359.
|
| 9. |
Pinho-Ribeiro FA, Fattori V, Zarpelon AC, et al. Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-κB and oxidative stress. Inflammopharmacology, 2016, 24(2-3): 97-107.
|
| 10. |
莫翠萍, 任力杰, 趙振富, 等. BMSCs 移植治療大鼠脊髓損傷效果及局部細胞因子表達變化. 中國修復重建外科雜志, 2016, 30(3): 265-271.
|
| 11. |
Mollica L, De Marchis F, Spitaleri A, et al. Glycyrrhizin binds to high-mobility group Box 1 protein and inhibits its cytokine activities. Chem Biol, 2007, 14(4): 431-441.
|
| 12. |
de Mos M, Laferrière A, Millecamps M, et al. Role of NFkappaB in an animal model of complex regional pain syndrome-typeⅠ (CRPS-Ⅰ). J Pain, 2009, 10(11): 1161-1169.
|
| 13. |
Li G, Wu X, Yang L, et al. TLR4-mediated NF-κB signaling pathway mediates HMGB1-induced pancreatic injury in mice with severe acute pancreatitis. Int J Mol Med, 2016, 37(1): 99-107.
|
| 14. |
朱雙龍, 段會全, 劉英富, 等. 柴胡皂苷 a 對大鼠急性脊髓損傷的神經保護作用與機制研究. 中國修復重建外科雜志, 2017, 31(7): 825-829.
|
| 15. |
Wang KC, Tsai CP, Lee CL, et al. Elevated plasma high-mobility group Box 1 protein is a potential marker for neuromyelitis optica. Neuroscience, 2012, 226(18): 510-516.
|
| 16. |
Yang J, Liu X, Zhou Y, et al. Hyperbaric oxygen alleviates experimental (spinal cord) injury by downregulating HMGB1/NF-κB expression. Spine (Phila Pa 1976), 2013, 38(26): E1641-1648.
|
| 17. |
Li L, Ni L, Eugenin EA, et al. Toll-like receptor 9 antagonism modulates astrocyte function and preserves proximal axons following spinal cord injury. Brain Behav Immun, 2019, 80: 328-343.
|
| 18. |
Papatheodorou A, Stein AB, Bank M, et al. High-mobility group box 1 (HMGB1) is elevated systemically in persons with acute or chronic traumatic spinal cord injury. J Neurotrauma, 2016, 34(3): 746-754.
|
| 19. |
Sun L, Li M, Ma X, et al. Inhibition of HMGB1 reduces rat spinal cord astrocytic swelling and AQP4 expression after oxygen-glucose deprivation and reoxygenation via TLR4 and NF-κB signaling in an IL-6-dependent manner. J Neuroinflamm, 2017, 14(1): 231.
|
| 20. |
Tang X, Davies JE, Davies SJ. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res, 2003, 71(3): 427-444.
|
| 21. |
Schwab JM, Zhang Y, Kopp MA, et al. The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Exp Neurol, 2014, 258: 121-129.
|
| 22. |
Li XQ, Chen FS, Tan WF, et al. Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia-reperfusion by inhibiting HMGB1 and the TLR3-cytokine pathway. J Neuroinflamm, 2017, 14(1): 205.
|
| 23. |
Wang Q, Ding Q, Zhou Y, et al. Ethyl pyruvate attenuates spinal cord ischemic injury with a wide therapeutic window through inhibiting high-mobility group box 1 release in rabbits. Anesthesiology, 2009, 110(6): 1279-1286.
|
| 24. |
Chen H, Guan B, Wang B, et al. Glycyrrhizin prevents hemorrhagic transformation and improves neurological outcome in ischemic stroke with delayed thrombolysis through targeting peroxynitrite-mediated HMGB1 signaling. Transl Stroke Res, 2019. https://doi.org/10.1007/s12975-019-00772-1.
|
| 25. |
Ieong C, Sun H, Wang Q, et al. Glycyrrhizin suppresses the expressions of HMGB1 and ameliorates inflammative effect after acute subarachnoid hemorrhage in rat model. J Clin Neurosci, 2018, 47: 278-284.
|
| 26. |
Su X, Wang H, Zhao J, et al. Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NF-kappaB pathway after traumatic brain injury in the rat. Mediat Inflamm, 2011, 2011: 807142.
|
| 27. |
Deng G, Gao Y, Cen Z, et al. miR-136-5p Regulates the inflammatory response by targeting the IKKβ/NF-κB/A20 pathway after spinal cord injury. Cell Physiol Biochem, 2018, 50(2): 512-524.
|